LAVA Therapeutics Statistics
Total Valuation
LVTX has a market cap or net worth of $70.45 million. The enterprise value is -$26.65 million.
| Market Cap | 70.45M |
| Enterprise Value | -26.65M |
Important Dates
The next estimated earnings date is Thursday, June 6, 2024, before market open.
| Earnings Date | Jun 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LVTX has 26.29 million shares outstanding. The number of shares has increased by 3.12% in one year.
| Shares Outstanding | 26.29M |
| Shares Change (YoY) | +3.12% |
| Shares Change (QoQ) | +6.75% |
| Owned by Insiders (%) | 28.72% |
| Owned by Institutions (%) | 32.37% |
| Float | 12.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.37 |
| Forward PS | n/a |
| PB Ratio | 1.27 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.62, with a Debt / Equity ratio of 0.12.
| Current Ratio | 6.62 |
| Quick Ratio | 6.49 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 15.04 |
Financial Efficiency
Return on equity (ROE) is -68.50% and return on invested capital (ROIC) is -75.23%.
| Return on Equity (ROE) | -68.50% |
| Return on Assets (ROA) | -35.70% |
| Return on Capital (ROIC) | -75.23% |
| Revenue Per Employee | $203,273 |
| Profits Per Employee | -$1.26M |
| Employee Count | 37 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LVTX has paid $303,541 in taxes.
| Income Tax | 303,541 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.80% in the last 52 weeks. The beta is 0.68, so LVTX's price volatility has been lower than the market average.
| Beta (1Y) | 0.68 |
| 52-Week Price Change | +40.80% |
| 50-Day Moving Average | 3.00 |
| 200-Day Moving Average | 1.99 |
| Relative Strength Index (RSI) | 40.96 |
| Average Volume (30 Days) | 1,096,769 |
Short Selling Information
The latest short interest is 121,321, so 0.46% of the outstanding shares have been sold short.
| Short Interest | 121,321 |
| Short Previous Month | 193,837 |
| Short % of Shares Out | 0.46% |
| Short % of Float | 1.00% |
| Short Ratio (days to cover) | 0.61 |
Income Statement
In the last 12 months, LVTX had revenue of $7.52 million and -$46.64 million in losses. Loss per share was -$1.71.
| Revenue | 7.52M |
| Gross Profit | 3.58M |
| Operating Income | -47.06M |
| Pretax Income | -45.36M |
| Net Income | -46.64M |
| EBITDA | -47.20M |
| EBIT | -48.59M |
| Loss Per Share | -$1.71 |
Balance Sheet
The company has $103.98 million in cash and $6.87 million in debt, giving a net cash position of $97.11 million or $3.69 per share.
| Cash & Cash Equivalents | 103.98M |
| Total Debt | 6.87M |
| Net Cash | 97.11M |
| Net Cash Per Share | $3.69 |
| Equity / Book Value | 55.68M |
| Book Value Per Share | 2.12 |
| Working Capital | 91.34M |
Cash Flow
In the last 12 months, operating cash flow was -$42.40 million and capital expenditures -$794,212, giving a free cash flow of -$43.19 million.
| Operating Cash Flow | -42.40M |
| Capital Expenditures | -794,212 |
| Free Cash Flow | -43.19M |
| FCF Per Share | -$1.62 |
Margins
Gross margin is 47.55%, with operating and profit margins of -625.67% and -620.09%.
| Gross Margin | 47.55% |
| Operating Margin | -625.67% |
| Pretax Margin | -603.14% |
| Profit Margin | -620.09% |
| EBITDA Margin | -627.61% |
| EBIT Margin | -646.10% |
| FCF Margin | -574.31% |
Dividends & Yields
LVTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.12% |
| Shareholder Yield | -3.12% |
| Earnings Yield | -66.20% |
| FCF Yield | -61.31% |
Analyst Forecast
The average price target for LVTX is $6.00, which is 126.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.00 |
| Price Target Difference | 126.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 42.45% |
| EPS Growth Forecast (5Y) | -5.28% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LVTX has an Altman Z-Score of -1.66 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.66 |
| Piotroski F-Score | 1 |